Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synovial sarcoma.

E H Soule

    The American Journal of Surgical Pathology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Dr. Arthur Purdy Stout

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pigmented villonodular synovitis.

    Orthopedics·2014
    Same author

    Synovial sarcoma.

    Orthopedics·2014
    Same author

    Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I.

    Cancer·1988
    Same author

    Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study.

    Human pathology·1988
    Same author

    Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1988
    Same author

    Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center).

    Medical and pediatric oncology·1988
    Same journal

    Clinicopathologic and Molecular Analysis of Traditional Serrated Adenoma and Its Possible Precursor Lesions With Special Reference to RSPO Fusion Status: A Large Case Series From Single Institution.

    The American journal of surgical pathology·2026
    Same journal

    NF2/Merlin Immunohistochemistry Helps Distinguish Collecting Duct Carcinoma From Upper Tract Urothelial Carcinoma.

    The American journal of surgical pathology·2026
    Same journal

    Neuroendocrine Carcinoma of the Gallbladder: Clinicopathologic and Immunohistochemical Analysis of 31 Cases.

    The American journal of surgical pathology·2026
    Same journal

    Papillary Renal Neoplasm With Reverse Polarity Is a Distinct Distal Nephron-Derived Tumor With Unique Methylation Profile.

    The American journal of surgical pathology·2026
    Same journal

    Biallelic ARID1A Alterations: A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors.

    The American journal of surgical pathology·2026
    Same journal

    Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.

    The American journal of surgical pathology·2026
    See all related articles

    Area of Science:

    • Surgical Pathology
    • Oncology
    • Soft Tissue Tumors

    Background:

    • Review of Dr. Arthur Purdy Stout's contributions to surgical pathology.
    • Focus on soft tissue tumors, specifically synovial sarcoma.
    • Analysis of 185 Mayo Clinic patients treated for synovial sarcoma.

    Purpose of the Study:

    • To review the contributions of Dr. Stout to surgical pathology.
    • To analyze treatment outcomes for synovial sarcoma patients.
    • To identify prognostic factors influencing survival rates in synovial sarcoma.

    Main Methods:

    • Histologic subclassification of synovial sarcoma into biphasic, monophasic, and mixed patterns.
    • Survival rate analysis for 185 patients.
    • Comparison of survival rates based on patient demographics and tumor characteristics.

    Main Results:

    • Overall 5-year survival rate was 38%, 10-year rate was 23%.
    • Patients treated since 1960 showed improved survival (55% at 5 years, 38% at 10 years).
    • Favorable prognostic factors included female sex, younger age, and smaller tumor size (<5 cm).

    Conclusions:

    • Synovial sarcoma treatment has improved, particularly for patients diagnosed after 1960.
    • Tumor size, patient age, and sex are significant prognostic indicators.
    • Glandular differentiation may be associated with better outcomes, warranting further investigation.

    Related Experiment Videos